CARDAMA, GEORGINA A.; BUCCI, PAULA L.; LEMOS, JESÚS S.; LLAVONA, CANDELA; BENAVENTE, MICAELA A.; HELLMÉN, EVA; FARA, MARÍA LAURA; MEDRANO, EDUARDO; SPITZER, EDUARDO; DEMARCO, IGNACIO A.; SABELLA, PATRICIA; GARONA, JUAN; ALONSO, DANIEL F.

In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary Carcinoma

Animals; Año: 2023 vol. 13

MAGGIO, JULIÁN; CARDAMA, GEORGINA A.; ARMANDO, ROMINA G.; BALCONE, LARA; SOBOL, NATASHA T.; GOMEZ, DANIEL E.; MENGUAL GÓMEZ, DIEGO L.

Key role of PIN1 in telomere maintenance and oncogenic behavior in a human glioblastoma model

ONCOLOGY REPORTS; Año: 2023 vol. 49

BRIZUELA, MARTÍN EDUARDO; GOÑI, SANDRA ELIZABETH; CARDAMA, GEORGINA ALEXANDRA; ZINNI, MARÍA ALEJANDRA; CASTELLO, ALEJANDRO ANDRES; SOMMESE, LEANDRO MATÍAS; FARINA, HERNÁN GABRIEL

Correlation of SARS-CoV-2 Viral Load and Clinical Evolution of Pediatric Patients in a General Hospital From Buenos Aires, Argentina

Frontiers in Pediatrics; Año: 2022 vol. 10

CARDAMA, GEORGINA A.; MAGGIO, JULIAN; VALDEZ CAPUCCINO, LUCAS; GONZALEZ, NAZARENO; MATILLER, VALENTINA; ORTEGA, HUGO H.; PEREZ, GERMAN R.; DEMARCO, IGNACIO A.; SPITZER, EDUARDO; GOMEZ, DANIEL E.; LORENZANO MENNA, PABLO; ALONSO, DANIEL F.

Preclinical Efficacy and Toxicology Evaluation of RAC1 Inhibitor 1A-116 in Human Glioblastoma Models

Cancers; Año: 2022 vol. 14

KROLEWIECKI, ALEJANDRO; LIFSCHITZ, ADRIÁN; MORAGAS, MATÍAS; TRAVACIO, MARINA; VALENTINI, RICARDO; ALONSO, DANIEL F.; SOLARI, RUBÉN; TINELLI, MARCELO A.; CIMINO, RUBÉN O.; ÁLVAREZ, LUIS; FLEITAS, PEDRO E.; CEBALLOS, LAURA; GOLEMBA, MARCELO; FERNÁNDEZ, FLORENCIA; DE OLIVEIRA, DIEGO FERNÁNDEZ; ASTUDILLO, GERMAN; BAECK, INÉS; FARINA, JAVIER; CARDAMA, GEORGINA A.; MANGANO, ANDREA; SPITZER, EDUARDO; GOLD, SILVIA; LANUSSE, CARLOS

Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959](S258953702100239X)(10.1016/j.eclinm.2021.100959)

iScience; Año: 2021 vol. 39

KROLEWIECKI, ALEJANDRO; LIFSCHITZ, ADRIÁN; MORAGAS, MATÍAS; TRAVACIO, MARINA; VALENTINI, RICARDO; ALONSO, DANIEL F.; SOLARI, RUBÉN; TINELLI, MARCELO A.; CIMINO, RUBÉN O.; ÁLVAREZ, LUIS; FLEITAS, PEDRO E.; CEBALLOS, LAURA; GOLEMBA, MARCELO; FERNÁNDEZ, FLORENCIA; FERNÁNDEZ DE OLIVEIRA, DIEGO; ASTUDILLO, GERMAN; BAECK, INÉS; FARINA, JAVIER; CARDAMA, GEORGINA A.; MANGANO, ANDREA; SPITZER, EDUARDO; GOLD, SILVIA; LANUSSE, CARLOS

Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial

EClinicalMedicine; Año: 2021 vol. 37

TREBUCQ, LAURA; CARDAMA, GEORGINA; LORENZANO MENNA, PABLO; GOLOMBEK, DIEGO; CHIESA, JUAN; MARPEGAN, LUCIANO

Timing of Novel Drug 1A-116 to Circadian Rhythms Improves Therapeutic Effects against Glioblastoma

Pharmaceutics; Año: 2021 vol. 13

GONZÁLEZ, NAZARENO; CARDAMA, GEORGINA A.; CHINESTRAD, PATRICIO; ROBLES-VALERO, JAVIER; RODRÍGUEZ-FDEZ, SONIA; LORENZO-MARTÍN, L. FRANCISCO; BUSTELO, XOSÉ R.; LORENZANO MENNA, PABLO; GOMEZ, DANIEL E.

Computational and in vitro Pharmacodynamics Characterization of 1A-116 Rac1 Inhibitor: Relevance of Trp56 in Its Biological Activity

Frontiers in Cell and Developmental Biology; Año: 2020 vol. 8

CARDAMA, G.A.; ALONSO, D.F.; GONZALEZ, N.; MAGGIO, J.; GOMEZ, D.E.; ROLFO, C.; MENNA, P.L

Relevance of small GTPase Rac1 pathway in drug and radio-resistance mechanisms: Opportunities in cancer therapeutics

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY; Año: 2018 vol. 124 p. 29 - 36

JULIAN MAGGIO; NAZARENO GONZALEZ; GEORGINA A. CARDAMA; DANIEL E GOMEZ

Rho GTPases as molecular targets in cancer. Strategies and therapeutic opportunities

MEDICINA (BUENOS AIRES); Año: 2017 vol. 77 p. 497 - 504

CABRERA M; ECHEVERRIA E; REMES LENICOV F; CARDAMA GA; GONZALEZ M; DAVIO C; FERNANDEZ NC; LORENZANO MENNA P

Pharmacological Rac1 inhibitors with selective apoptotic activity in human acute leukemic cell lines

ONCOTARGET; Lugar: New York; Año: 2017 vol. 8 p. 98509 - 98523

GEORGINA A. CARDAMA; NAZARENO GONZALEZ; JULIAN MAGGIO; PABLO LORENZANO MENNA; DANIEL E. GOMEZ

Rho GTPases as therapeutic targets in cancer

INTERNATIONAL JOURNAL OF ONCOLOGY; Año: 2017 vol. 51 p. 1025 - 1034

NAZARENO GONZALEZ; GEORGINA A. CARDAMA; MARIA JULIETA COMIN; VALERIA I. SEGATORI; MARINA PIFANO; DANIEL F. ALONSO; DANIEL E. GOMEZ; PABLO LORENZANO MENNA

Pharmacological inhibition of Rac1-PAK1 axis restores tamoxifen sensitivity in human resistant breast cancer cells

CELLULAR SIGNALLING; Lugar: Amsterdam; Año: 2016

GEORGINA A. CARDAMA; PABLO LORENZANO MENNA

Dynamic interaction between glioma cells and their microenvironment: targeting Rac1 as a therapeutic approach

Cancer Cell & Microenvironment; Año: 2015 vol. 2

GEORGINA CARDAMA; NAZARENO GONZALEZ; MATIAS CIARLANTINI ; LUCIA GANDOLFI DONADÍO; MARIA J. COMIN; DANIEL F. ALONSO; PABLO LORENZANO MENNA; DANIEL E. GOMEZ

Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells

ONCOTARGETS AND THERAPY; Año: 2014 vol. 7 p. 2021 - 2033

GEORGINA A. CARDAMA; MARIA J. COMIN; LEANDRO HORNOS; NAZARENO GONZALEZ; LUCAS DEFELIPE; ADRIAN G. TURJANSKI; DANIEL F. ALONSO; DANIEL E GOMEZ; PABLO LORENZANO MENNA

Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY; Lugar: Oak Park; Año: 2014 vol. 14 p. 840 - 851

PABLO LORENZANO MENNA; GEORGINA A. CARDAMA; MARIA J. COMIN; DANIEL F. ALONSO; DANIEL E. GOMEZ

Rho GTPasas como blancos terapéuticos relevantes en cáncer y otras patologías humanas

MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2010 vol. 70 p. 555 - 564

PABLO LORENZANO MENNA; ROMINA L. PARERA; GEORGINA A. CARDAMA; DANIEL F. ALONSO; DANIEL E. GOMEZ; HERNAN G. FARINA

Enhanced cytostatic activity of statins in mouse mammary carcinoma cells overexpressing β2-chimaerin

MOLECULAR MEDICINE REPORTS; Lugar: Atenas; Año: 2009 vol. 2 p. 97 - 102

LAW RJ; HAMLIN JN; SIVRO A; MCCORRISTER SJ; CARDAMA GA; CARDONA ST

A functional phenylacetic acid catabolic pathway is required for full pathogenicity of Burkholderia cenocepacia in the Caenorhabditis elegans host model

JOURNAL OF BACTERIOLOGY; Año: 2008 vol. 190 p. 7209 - 7218